Roche has said it plans to UK price its latest multiple sclerosis drug Ocrevus in line with its close rival from Novartis - aiming to undercut some established rivals. Approved in Europe earlier this ...

A subcutaneous (SC) injection version of Roche’s big-selling multiple sclerosis therapy Ocrevus has matched the current intravenous form in a clinical trial and, according to the company, could boost ...

Kesimpta is a prescription medication used to treat clinically isolated syndrome and specific types of multiple sclerosis. Kesimpta comes as a liquid solution for injection under your skin. Common ...

Spinal cord lesions are more commonly seen in progressive forms of multiple sclerosis, and they can result in an increased risk of disability. In relapsing-remitting MS, which 80 to 85 percent of ...